Cellebrite Di Equity Stock Probability Of Bankruptcy
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
Cellebrite |
Cellebrite DI Equity Company odds of financial turmoil Analysis
Cellebrite's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Cellebrite Probability Of Bankruptcy | Over 100% |
Most of Cellebrite's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellebrite DI Equity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Cellebrite probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Cellebrite odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Cellebrite DI Equity financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Cellebrite DI Equity has a Probability Of Bankruptcy of 100%. This is 89.61% higher than that of the Software sector and significantly higher than that of the Information Technology industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Cellebrite Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in probability of bankruptcy category among its peers.
Cellebrite Fundamentals
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Number Of Shares Shorted | 356.81 K | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| Gross Profit | 219.91 M | |||
| EBITDA | 43.29 M | |||
| Net Income | (81.1 M) | |||
| Total Debt | 14.13 M | |||
| Book Value Per Share | (0.19) X | |||
| Cash Flow From Operations | 102.06 M | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 1.01 K | |||
| Beta | 1.52 | |||
| Total Asset | 540.4 M | |||
| Retained Earnings | 118.14 M | |||
| Working Capital | 168.26 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 540.4 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI Equity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |